Market Exclusive

Analyst Upgrades – Genocea Biosciences (NASDAQ:GNCA) Stock Gets Upgraded By Needham & Company LLC from Hold to Buy

Analyst Ratings For Genocea Biosciences (NASDAQ:GNCA)

Today, Genocea Biosciences (NASDAQ:GNCA) stock received an upgrade by Needham & Company LLC from Hold to Buy with a price target of $3.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Genocea Biosciences (NASDAQ:GNCA)
Genocea Biosciences (NASDAQ:GNCA) has insider ownership of 6.70% and institutional ownership of 12.02%.

Recent Trading Activity for Genocea Biosciences (NASDAQ:GNCA)
Shares of Genocea Biosciences closed the previous trading session at 0.93 up +0.02 1.78% with shares trading hands.

Exit mobile version